- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07434141
Postoperative Pain After Single-Cone Root Canal Obturation Using Three Sealers (POP-RCT)
Comparative Analysis of Postoperative Pain in Symptomatic Irreversible Pulpitis Teeth Following Single Cone Obturation Using Three Different Sealers: A Randomized Clinical Trial
The goal of this clinical trial is to compare post-treatment pain after root canal therapy in adults with irreversible pulpitis using different root canal sealers. The study will also evaluate the need for pain medication after treatment.
The main questions this study aims to answer are:
Does the type of root canal sealer affect the intensity of pain after treatment?
Does the type of sealer influence the number of analgesic tablets taken by participants?
How does pain change over time after treatment with different sealers?
Researchers will compare two bioceramic sealers (EndoSeal TCS and NeoSeal) with a resin-based sealer (AH Plus) to determine their effects on post-endodontic pain.
Participants will:
Receive root canal treatment using one of the study sealers
Report their pain intensity at specific time points after treatment
Record the number of analgesic tablets taken during the follow-up period
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tehran, Iran, 1439955991
- Tehran University of Medical Sciences, School of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 18 and 60 years
- Adequate oral and dental hygiene
- Prolonged positive response to cold test and electric pulp testing
- Clinical diagnosis of symptomatic irreversible pulpitis and symptomatic apical periodontitis in a first or second molar (maxillary or mandibular)
- Pulp exposure during caries removal accompanied by severe and profuse hemorrhage
- No radiographic evidence of periapical lesions
- Teeth with adequate restorative potential
- Absence of periodontal disease
Exclusion Criteria:
- Teeth that are non-restorable
- Presence of endodontic-periodontal (endo-perio) lesions
- Teeth with radiographic evidence of periapical lesions
- Teeth with internal or external root resorption
- Patients with systemic diseases classified as ASA II or higher
- Patients with a history of migraine
- Teeth with over-obturation or under-obturation greater than 2 mm from the radiographic apex
- Patients taking anti-anxiety medications
- Procedural duration exceeding two hours
- Known allergy to materials used in root canal treatment, including local anesthetics
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EndoSeal TCS
Participants receive single-visit root canal treatment using the bioceramic sealer EndoSeal TCS with the single-cone obturation technique.
Postoperative pain intensity and analgesic consumption are recorded at predefined time intervals
|
Bioceramic, premixed calcium silicate-based root canal sealer used for obturation with the single-cone technique during root canal treatment
|
|
Experimental: NeoSealer
Participants receive single-visit root canal treatment using the bioceramic sealer NeoSealer with the single-cone obturation technique.
Postoperative pain intensity and analgesic consumption are recorded at predefined time intervals.
|
Fast-setting calcium silicate-based bioceramic root canal sealer used for obturation with the single-cone technique during root canal treatment
|
|
Experimental: AH Plus
Participants receive single-visit root canal treatment using the resin-based sealer AH Plus with the single-cone obturation technique.
Postoperative pain intensity and analgesic consumption are recorded at predefined time intervals
|
Epoxy resin-based root canal sealer used for obturation with the single-cone technique during root canal treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-Endodontic Pain Intensity
Time Frame: Pain will be assessed at 6, 12,18, 24, and 48 hours post-treatment
|
Pain intensity experienced by participants after root canal treatment will be measured using a Visual Analog Scale (VAS; 0-10 numeric rating scale), where: 0 = no pain 10 = worst imaginable pain Higher scores indicate greater pain intensity (worse outcome). Participants will also record the number of analgesic tablets consumed during the first 48 hours after treatment. The maximum VAS pain score recorded during the first 48 hours will be considered the primary outcome |
Pain will be assessed at 6, 12,18, 24, and 48 hours post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analgesic Consumption
Time Frame: Within 48 hours post-treatment
|
Total number of analgesic tablets consumed by participants during the first 48 hours after treatment
|
Within 48 hours post-treatment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Shole Ghabraei, Professor, Tehran university of medical science, school of dentistry
- Principal Investigator: Hadi Assadian, Assistant Professor, Tehran university of medical science, school of dentistry
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IR.TUMS.DENTISTRY.REC.1404.021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Symptomatic Irreversible Pulpitis (SIP)
-
Ondokuz Mayıs UniversityRecruitingSymptomatic Irreversible Pulpitis (SIP)Turkey (Türkiye)
-
Cairo UniversityNot yet recruitingSymptomatic Irreversible Pulpitis (SIP)Egypt
-
Future University in EgyptActive, not recruitingSymptomatic Irreversible Pulpitis (SIP)Egypt
-
Dow University of Health SciencesRecruitingSymptomatic Irreversible Pulpitis (SIP)Pakistan
-
Cairo UniversityCompletedSymptomatic Irreversible Pulpitis (SIP)Egypt
-
University of FujairahRecruitingSymptomatic Irreversible Pulpitis | Symptomatic Irreversible Pulpitis (SIP)United Arab Emirates
-
Cumhuriyet UniversityCompletedSymptomatic Irreversible Pulpitis (SIP)Turkey (Türkiye)
-
Future University in EgyptActive, not recruitingSymptomatic Irreversible Pulpitis (SIP)Egypt
-
HITEC-Institute of Medical SciencesRecruitingSymptomatic Irreversible PulpitisPakistan
-
Zahoor khanHITEC-Institute of Medical SciencesCompletedEvaluating the Combined Effect of Oral Premedications on Inferior Alveolar Nerve Block EffectivenessSymptomatic Irreversible PulpitisPakistan
Clinical Trials on Endoseal TCS
-
NYU Langone HealthWithdrawn
-
Charite University, Berlin, GermanyNational Institute of Mental Health (NIMH); University of Trás-os-Montes and... and other collaboratorsCompletedSexual Behavior | Behavior Problems | Behavioural Disorder | Child Sexual Abuse Material (CSAM) Consumption | Online BehaviourGermany, Spain
-
Boston University Charles River CampusNational Institute on Deafness and Other Communication Disorders (NIDCD)Not yet recruitingDyslexia | Healthy Participants | Stuttering, DevelopmentalUnited States
-
LEO PharmaRecruitingAtopic DermatitisItaly, Spain, Canada, Germany, Belgium, United Kingdom, United States, Poland, Croatia, Romania, Netherlands, Ireland, South Korea
-
Institut GuttmannCastellers de la Vila de GràciaRecruitingNeuropathic Pain | Spinal Cord Injuries | Central Neuropathic PainSpain
-
LEO PharmaCompleted
-
University of Colorado, DenverChildren's Hospital Colorado; Bright by 3; Daniels Fund; Piton Foundation; Gantz...Terminated
-
Incyte CorporationRecruitingPregnancy Related | Atopic DermatitisUnited States
-
Peking University Third HospitalCompletedParkinson DiseaseChina
-
Tongji HospitalCompletedLiver Carcinoma Resectable